ISAD International Survey on Topical Corticosteroid Maintenance Therapy in Atopic Dermatitis (CE)

Dear ISAD colleagues,

Following recent discussions with the TSW community, an important gap has been identified: the literature provides very limited practical guidance on the actual quantities (grams/month) and potencies of topical corticosteroids (TCS) recommended for maintenance therapy in atopic dermatitis (AD), outside acute flares and across age groups.

To better document real-world expert practice, ISAD is launching a short international survey among clinicians who prescribe TCS for AD.

This survey is intended as a validation step following a previous survey conducted among ISAD members. Please note that it refers only to the maintenance phase of topical corticosteroid (TCS) prescriptions.

Our aim is to obtain practical quantitative data on:

• monthly amounts prescribed for maintenance therapy
• potency selection from infancy to adulthood
• frequency of proactive use
• duration of prescriptions and frequency of follow-up visits
  
  An open text box is provided at the end of the questionnaire where you may specify additional aspects not covered in the survey (e.g., potency, anatomical locations, or other considerations).

These data will help inform ISAD educational and consensus initiatives.

⏱ Estimated completion time: 3–4 minutes
📊 Platform: secure online survey allowing rapid anonymous statistical analysis
🗳 A second validation poll may be conducted among ISAD annual meeting participants to confirm and refine the results.

Thank you for contributing to this collective effort.

— ISAD Executive Committee

Important note on potency classification

Because potency classifications vary internationally, please answer according to the closest equivalent in your country even if brand names differ.
➜ Click for examples provided only for orientation